Sep 28 2016

The life sciences sector has been rocked by a series of high profile U.S. court decisions invalidating diagnostic method patents. The situation in Canada remains to be determined. Nevertheless, the Canadian Intellectual Property Office (CIPO) continues to look southward when determining what should and shouldn’t be considered patentable subject matter in Canada.

Read the full article, written by Andrew Montague and Andrew Kaikai (former associates): U.S. diagnostic method patents under siege

This article originally appeared in the September 2, 2016 issue of The Lawyers Weekly.

Back to blog overview

Tags: CIPO, The Lawyers Weekly